Patent details

Basic Information

Publication number:

EP2552425

PCT Application Number:

PCT/US/2011/031135

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117151209

PCT Publication Number:

WO/2011/123866

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ABUSE-DETERRENT TRANSDERMAL FORMULATIONS OF OPIATE AGONISTS AND AGONIST-ANTAGONISTS

French Title of Invention:

FORMULATIONS TRANSDERMIQUES INVIOLABLES D'AGONISTES ET D'AGONISTES-ANTAGONISTES D'OPIACÉS

German Title of Invention:

MISSBRAUCHSSICHERE TRANSDERMALE FORMULIERUNGEN VON OPIAT-AGONISTEN UND -AGONIST-ANTAGONISTEN

SPC Number:

Dates

Filing date:

04/04/2011

Grant date:

27/07/2016

EP Publication Date:

27/07/2016

PCT Publication Date:

06/10/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/02/2013

EP B1 Publication Date:

27/07/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/04/2017

Expiration date:

04/04/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/04/2011

 

 

Name:

Buzzz Pharmaceuticals Limited

Address:

15 Main Street Raheny, Dublin 5, Ireland (IE)

Inventor

1

Name:

LI Guohua

Address:

United States (US)

2

Name:

HOWARD Jeffery, Lynn

Address:

United States (US)

3

Name:

GOLINSKI Miroslaw, Jerzy

Address:

United States (US)

4

Name:

BANKS Stan, Lee

Address:

United States (US)

5

Name:

STINCHCOMB Audra, Lynn

Address:

United States (US)

Priority

Priority Number:

320526 P

Priority Date:

02/04/2010

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/70;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages